TRCT
BHVN icon

Tower Research Capital (TRC)’s Biohaven BHVN Stock Holding History

Tower Research Capital (TRC)’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$147K Sell
9,880
-3,400
-26% -$36.6K ﹤0.01% 1919
2026
Q1 		$112K Buy
13,280
+3,707
+39% +$40.6K ﹤0.01% 2090
2025
Q4 		$108K Buy
9,573
+3,001
+46% +$37.2K ﹤0.01% 1889
2025
Q3 		$98.6K Sell
6,572
-1,459
-18% -$21.2K ﹤0.01% 2004
2025
Q2 		$113K Buy
8,031
+5,341
+199% +$95.2K ﹤0.01% 2278
2025
Q1 		$64.7K Sell
2,690
-9,490
-78% -$335K ﹤0.01% 2039
2024
Q4 		$455K Buy
12,180
+11,781
+2,953% +$550K 0.01% 1135
2024
Q3 		$19.9K Sell
399
-15,180
-97% -$591K ﹤0.01% 3240
2024
Q2 		$541K Buy
15,579
+11,053
+244% +$437K 0.01% 1275
2024
Q1 		$248K Sell
4,526
-1,231
-21% -$61K 0.01% 1288
2023
Q4 		$246K Buy
5,757
+3,908
+211% +$122K ﹤0.01% 1928
2023
Q3 		$48.1K Sell
1,849
-4,828
-72% -$100K ﹤0.01% 2578
2023
Q2 		$160K Buy
6,677
+2,809
+73% +$48.4K 0.01% 1718
2023
Q1 		$53K Sell
3,868
-9,188
-70% -$146K ﹤0.01% 2432
2022
Q4 		$182K Buy
+13,056
New +$184K 0.01% 1364

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tower Research Capital (TRC)'s BHVN Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Biohaven (BHVN) stake by 26% in Q2 2026, selling an estimated $36.6K and leaving 9,880 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #1919.

Tower Research Capital (TRC) first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $541K in Q2 2024. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Tower Research Capital (TRC) held 9,880 shares of Biohaven worth $147K as of Q2 2026.
  • Tower Research Capital (TRC) sold 3,400 Biohaven shares in Q2 2026, an estimated $36.6K.
  • Biohaven made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #1919 holding.
  • Tower Research Capital (TRC) first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • Tower Research Capital (TRC)'s Biohaven position peaked at $541K in Q2 2024.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.